Frankfurt - Delayed Quote EUR
SELLAS Life Sciences Group, Inc. (RXK3.F)
1.1760
+0.0960
+(8.89%)
At close: April 23 at 3:28:04 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -- | -- | -- | 16.42M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 32.85M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RXK3.F | -- | -- | -- | -- |
| S&P 500 | 6.85% | 4.67% | 8.41% | 14.16% |
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 11/22/2023 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 9/7/2023 |
| Maintains | Alliance Global Partners: Buy | 11/15/2022 |
| Maintains | Cantor Fitzgerald: Overweight | 6/28/2022 |
| Initiated | Cantor Fitzgerald: Overweight | 7/21/2021 |
| Upgrade | Maxim Group: Hold to Buy | 11/15/2019 |
Related Tickers
1OT.F Ovid Therapeutics Inc.
0.1960
-5.77%
AXD2.F Heron Therapeutics, Inc.
1.8750
+13.36%
HTD.SG Corcept Therapeutics Inc
61.76
+11.12%
1VT.MU Viking Therapeutics Inc
22.37
+7.65%
EXOZ eXoZymes, Inc.
13.53
+14.76%
AVBP ArriVent BioPharma, Inc.
21.08
+3.94%
BVNRY Bavarian Nordic A/S
7.72
0.00%
RAPP Rapport Therapeutics, Inc.
11.38
-1.47%
GYRE Gyre Therapeutics, Inc.
9.19
+6.37%
BCAX Bicara Therapeutics Inc.
15.51
+12.23%